These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2226211)

  • 1. Centrally acting sympatholytic agents in the treatment of congestive heart failure. A review of the literature.
    Manmontri A; MacLeod SM
    Drugs; 1990 Aug; 40(2):169-75. PubMed ID: 2226211
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of centrally acting sympatholytic agents in the management of hypertension.
    Oster JR; Epstein M
    Arch Intern Med; 1991 Aug; 151(8):1638-44. PubMed ID: 1872668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sympathetic inhibition with clonidine prolongs survival in experimental chronic heart failure.
    Zhang Y; Cheng Z
    Int J Cardiol; 2000 Apr; 73(2):157-62; discussion 163-4. PubMed ID: 10817854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of sympatholytic and vasodilator drugs.
    Moyer JH
    Pa Med; 1984 Jan; 87(1):34-42. PubMed ID: 6144088
    [No Abstract]   [Full Text] [Related]  

  • 5. [Centrally acting sympathetic inhibitors for therapy of patients with hypertension].
    Kawasaki H
    Nihon Rinsho; 1997 Aug; 55(8):2081-5. PubMed ID: 9284427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative antihypertensive effects of guanabenz and methyldopa.
    Walker BR; Deitch MW; Schneider BE; Hare LE
    Clin Ther; 1981; 4(4):275-84. PubMed ID: 7332915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonidine and heart failure.
    Giles TD
    Hypertension; 1996 May; 27(5):1187-8. PubMed ID: 8621215
    [No Abstract]   [Full Text] [Related]  

  • 8. The autonomic nervous system in congestive heart failure.
    Francis GS; Cohn JN
    Annu Rev Med; 1986; 37():235-47. PubMed ID: 2871803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct Vasodilators and Sympatholytic Agents.
    McComb MN; Chao JY; Ng TM
    J Cardiovasc Pharmacol Ther; 2016 Jan; 21(1):3-19. PubMed ID: 26033778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abrupt cessation of treatment in hypertension: consideration of clinical features, mechanisms, prevention and management of the discontinuation syndrome.
    Houston MC
    Am Heart J; 1981 Sep; 102(3 Pt 1):415-30. PubMed ID: 6115570
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacology update: hypotensive agents. Part II: Antiadrenergic agents.
    Romankiewicz JA
    J Pract Nurs; 1979 Aug; 29(8):13-5. PubMed ID: 257005
    [No Abstract]   [Full Text] [Related]  

  • 12. Guanabenz versus methyldopa in the therapy of mild-to-moderate hypertension.
    Rosendorff C
    S Afr Med J; 1982 Sep; 62(13):435-7. PubMed ID: 7051365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacotherapy of arterial hypertension].
    Gessler U; Pilgrim R
    Fortschr Med; 1977 Aug; 95(31):1912-5. PubMed ID: 892686
    [No Abstract]   [Full Text] [Related]  

  • 14. Progress in the treatment of essential hypertension.
    Sharma PL; Pandhi P
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23 Suppl 1():S54-61. PubMed ID: 2432023
    [No Abstract]   [Full Text] [Related]  

  • 15. What patients with hypertension should know about their medication.
    Bullen MU
    Drugs; 1980 May; 19(5):373-9. PubMed ID: 6104590
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical experiences in antihypertensive treatment with guanabenz or clonidine in combination with thiazide].
    Tschöpe W; Orth H; Ritz E
    Verh Dtsch Ges Inn Med; 1978; (84):820-4. PubMed ID: 369211
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of cardiac complications in hyperthyroidism].
    Carlier J
    Rev Med Liege; 1973 Sep; 28(17):601-5. PubMed ID: 4148306
    [No Abstract]   [Full Text] [Related]  

  • 18. [Centrally-acting antihypertensive drugs].
    Takishita S; Yamazato M
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():591-5. PubMed ID: 15171442
    [No Abstract]   [Full Text] [Related]  

  • 19. Office management of hypertension.
    Finnerty FA
    Compr Ther; 1984 Feb; 10(2):16-21. PubMed ID: 6142783
    [No Abstract]   [Full Text] [Related]  

  • 20. [Possibilities and limitations of hypertensive therapy].
    Kaufmann W; Helber A
    Med Welt; 1974 Dec; 25(49):2065-71. PubMed ID: 4444503
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.